|
Pre-vaccination period (2002–2005)
|
Intermediate period (2006–2007)
|
Funded vaccination period (2008–2009)
|
Reductiona
|
---|
|
Numbers of patients (%)
|
Mean numbers/year (95% CI)
|
Numbers of patients (%)
|
Mean numbers/year (95% CI)
|
Numbers of patients (%)
|
Mean numbers/year (95% CI)
|
Decreased by (%)
|
---|
0–11 mos
|
360 (35.1)
|
90.0 (80.2–99.8)
|
113 (30.4)
|
56.5 (44.7–68.3)
|
22 (16.4)
|
11.0 (2.7–19.3)
|
87.8
|
12–23 mos
|
300 (29.2)
|
75.0 (62.8–87.2)
|
125 (33.6)
|
62.5 (37.6–87.4)
|
55 (41.1)
|
27.5 (7.4–47.6)
|
63.3
|
2–5 yrs
|
254 (24.8)
|
63.5 (50.8–76.2)
|
110 (29.6)
|
55.0 (36.5–73.5)
|
48 (35.8)
|
24.0 (11.5–36.5)
|
62.2
|
6–10 yrs
|
76 (7.4)
|
19.0 (15.1–22.9)
|
19 (5.1)
|
9.5 (8.3–10.7)
|
6 (4.5)
|
3.0 (1.6–4.4)
|
84.2
|
11–18 yrs
|
36 (3.5)
|
9.0 (4.1–13.9)
|
5 (1.3)
|
2.5 (1.8–3.4)
|
3 (2.2)
|
1.0 (0.8–2.2)
|
88.9
|
All
|
1026 (100)
|
256.5 (222.2–290.8)
|
372 (100)
|
186.0 (119.5–252.5)
|
134 (100)
|
67.0 (22.7–111.3)
|
73.9
|
- Abbreviations: mos months, yrs years, CI confidence interval.
-
aReduction is calculated between mean numbers per year of the pre-vaccination period and the funded vaccination period (decrease in percentage).